November 22, 2022

Aide Health secures $1.2m pre-seed investment to advance the way patients and clinicians manage long-term conditions

Aide Health founders Ian Wharton and Brian Snyder
Ian Wharton
Founder, Chief Executive Officer

Health-tech startup Aide Health has raised $1.2m in pre-seed funding led by Hambro Perks through its EIS fund, with participation from Fuel Ventures, 1818 Ventures and APX Ventures.

Launched by co-founders Ian Wharton, CEO, and Brian Snyder, COO, Aide is a digital platform that helps patients and their clinicians better understand and manage long-term health conditions, currently affecting over 26 million people in the UK.

In 50% of cases, people struggle to follow the treatment as prescribed by their clinician, lowering their quality of life and placing added strain on the resources of the health service.

Aide provides clinicians with a platform to create and remotely monitor health plans for people with chronic disease, paired with a mobile app for the patient which acts as a co-pilot through their care. Using natural language, Aide has short, daily conversations to help with the day-to-day management of health conditions through medicines optimisation, structured monitoring and structured education.

The service is currently being used by the NHS, with a pilot launched earlier this year supporting people aged between 18-75 with asthma or type-2 diabetes. Aide has a specific focus on meeting the rising challenge of comorbidity and will soon be launching pathways for hypertension and chronic pain.

Ian Wharton, co-founder and CEO at Aide Health, says:

Like many people, I know first-hand the frustrations of trying to manage long-term conditions. Our goal is to give both patients and clinicians the tools and insights they need to have better conversations and make more informed treatment decisions together. The pilot in NHS England is our first step towards making Aide available to everyone with chronic illness.

Nicholas Sharp, head of Hambro Perks Growth EIS Fund, commented:

Ian and Brian’s vision and experience impressed us from the start, and we believe that Aide Health has the potential to be a hugely important tool for both clinicians and patients for managing long-term health conditions. Hambro Perks has a long track record of backing healthtech companies as part of our aim to invest in companies that make the world a better place. Aide Health and Ian’s team were therefore an obvious choice for us, and we look forward to supporting them on their growth journey.

About Aide Health

Launched in 2021, Aide Health is a digital health service that helps patients and their clinicians better understand and manage long-term conditions. The service connects a browser-based tool for the clinician (enabling the creation and remote monitoring of Health Plans for people with chronic disease) with a mobile app for the patient, which serves as a 24/7 companion through prescribed care.

About Hambro Perks

Hambro Perks is a London-headquartered international investment firm focussed on technology investing. We partner with founders and entrepreneurs to support growth businesses at all stages of the investment cycle.

Hambro Perks has specialised and dedicated investment teams, working across a number of funds. In addition to their flagship Venture, EIS and co-investment funds, Hambro Perks offers a number of specialist differentiated investment strategies, including Hambro Perks Environmental Technology, Special Situations, and Access, which invests in venture secondaries.


For more information, please contact


Other articles you might like